Technical Analysis for SAVA - Cassava Sciences, Inc.

Grade Last Price % Change Price Change
A 120.03 -2.72% -3.35
SAVA closed down 2.55 percent on Friday, July 23, 2021, on 1.27 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Aug 10
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical SAVA trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction -2.72%
Stochastic Reached Overbought Strength -2.72%
Upper Bollinger Band Walk Strength -2.72%
Multiple of Ten Bullish Other -2.72%
Inside Day Range Contraction -2.72%
Wide Bands Range Expansion -2.72%
Above Upper BB Strength -2.72%
Overbought Stochastic Strength -2.72%
Upper Bollinger Band Touch Strength -2.72%
MACD Bullish Signal Line Cross Bullish -5.20%
Older End-of-Day Signals for SAVA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% 2 minutes ago
Rose Above Previous Day's High 23 minutes ago
New 52 Week High 23 minutes ago
3x Volume Pace 23 minutes ago
2x Volume Pace 23 minutes ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Nervous System Disorders Biomarker Psychiatric Diagnosis Psychiatry Transdermal Abnormal Psychology

Is SAVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 130.33
52 Week Low 2.78
Average Volume 2,852,996
200-Day Moving Average 39.37
50-Day Moving Average 75.63
20-Day Moving Average 95.27
10-Day Moving Average 100.33
Average True Range 11.70
ADX 49.66
+DI 36.95
-DI 12.28
Chandelier Exit (Long, 3 ATRs) 95.23
Chandelier Exit (Short, 3 ATRs) 107.90
Upper Bollinger Bands 122.72
Lower Bollinger Band 67.81
Percent B (%b) 1.01
BandWidth 57.63
MACD Line 10.16
MACD Signal Line 7.93
MACD Histogram 2.2366
Fundamentals Value
Market Cap 4.31 Billion
Num Shares 35 Million
EPS -0.27
Price-to-Earnings (P/E) Ratio -450.29
Price-to-Sales 0.00
Price-to-Book 11.31
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 143.90
Resistance 3 (R3) 142.72 134.71 140.48
Resistance 2 (R2) 134.71 129.48 135.30 139.34
Resistance 1 (R1) 129.04 126.25 125.04 130.22 138.20
Pivot Point 121.03 121.03 119.02 121.62 121.03
Support 1 (S1) 115.36 115.80 111.36 116.54 108.56
Support 2 (S2) 107.35 112.57 107.94 107.42
Support 3 (S3) 101.68 107.35 106.28
Support 4 (S4) 102.86